Search research articles
Contact Us
Filters
Showing results (371-380 of 561) with videos related to
Page
of 57
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 18, 2026
Addressing Gaps in Parkinson's Disease Etiology: The Need for a Polyexposure Score
Njideka U Okubadejo, Eva Schaeffer, Alastair J Noyce, et al.
Journal of Parkinson'S Disease
|
July 25, 2018
Categorising Visual Hallucinations in Early Parkinson's Disease
Benjamin J Clegg, Gordon W Duncan, Tien K Khoo, et al.
Nature Genetics
|
December 1, 1995
Familial cylindromatosis (turban tumour syndrome) gene localised to chromosome 16q12-q13: evidence for its role as a tumour suppressor gene
P J Biggs, R Wooster, D Ford, et al.
American Journal of Human Genetics
|
December 1, 1993
A large, dominant pedigree of atrioventricular septal defect (AVSD): exclusion from the Down syndrome critical region on chromosome 21
L Wilson, A Curtis, J R Korenberg, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 2, 2013
Rapid eye movement sleep behavior disorder in Parkinson's disease: magnetic resonance imaging study
Andrew H Ford, Gordon W Duncan, Michael J Firbank, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
February 14, 2006
Characteristics of visual hallucinations in Parkinson disease dementia and dementia with lewy bodies
Urs P Mosimann, Elise N Rowan, Cassie E Partington, et al.
Journal of Medical Genetics
|
May 1, 1991
The UK Northern region genetic register for familial adenomatous polyposis coli: use of age of onset, congenital hypertrophy of the retinal pigment epithelium, and DNA markers in risk calculations
J Burn, P Chapman, J Delhanty, et al.
Neurology
|
July 1, 1994
The effect of entacapone (OR-611) on brain [18F]-6-L-fluorodopa metabolism: implications for levodopa therapy of Parkinson's disease
G V Sawle, D J Burn, P K Morrish, et al.
International Journal of Geriatric Psychiatry
|
December 8, 2016
Cognitive impairment in Parkinson's disease: impact on quality of life of carers
R A Lawson, A J Yarnall, F Johnston, et al.
The Journal of Bone and Joint Surgery. British Volume
|
February 29, 2012
The early radiological results of the uncemented Oxford medial compartment knee replacement
G J Hooper, A R Maxwell, B Wilkinson, et al.
Page
of 57
Search research articles
Search
Showing results (371-380 of 561) with videos related to
Sort By:
Page
of 57
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 18, 2026
Addressing Gaps in Parkinson's Disease Etiology: The Need for a Polyexposure Score
Njideka U Okubadejo, Eva Schaeffer, Alastair J Noyce, et al.
Journal of Parkinson'S Disease
|
July 25, 2018
Categorising Visual Hallucinations in Early Parkinson's Disease
Benjamin J Clegg, Gordon W Duncan, Tien K Khoo, et al.
Nature Genetics
|
December 1, 1995
Familial cylindromatosis (turban tumour syndrome) gene localised to chromosome 16q12-q13: evidence for its role as a tumour suppressor gene
P J Biggs, R Wooster, D Ford, et al.
American Journal of Human Genetics
|
December 1, 1993
A large, dominant pedigree of atrioventricular septal defect (AVSD): exclusion from the Down syndrome critical region on chromosome 21
L Wilson, A Curtis, J R Korenberg, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 2, 2013
Rapid eye movement sleep behavior disorder in Parkinson's disease: magnetic resonance imaging study
Andrew H Ford, Gordon W Duncan, Michael J Firbank, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
February 14, 2006
Characteristics of visual hallucinations in Parkinson disease dementia and dementia with lewy bodies
Urs P Mosimann, Elise N Rowan, Cassie E Partington, et al.
Journal of Medical Genetics
|
May 1, 1991
The UK Northern region genetic register for familial adenomatous polyposis coli: use of age of onset, congenital hypertrophy of the retinal pigment epithelium, and DNA markers in risk calculations
J Burn, P Chapman, J Delhanty, et al.
Neurology
|
July 1, 1994
The effect of entacapone (OR-611) on brain [18F]-6-L-fluorodopa metabolism: implications for levodopa therapy of Parkinson's disease
G V Sawle, D J Burn, P K Morrish, et al.
International Journal of Geriatric Psychiatry
|
December 8, 2016
Cognitive impairment in Parkinson's disease: impact on quality of life of carers
R A Lawson, A J Yarnall, F Johnston, et al.
The Journal of Bone and Joint Surgery. British Volume
|
February 29, 2012
The early radiological results of the uncemented Oxford medial compartment knee replacement
G J Hooper, A R Maxwell, B Wilkinson, et al.
Page
of 57